Sökning: id:"swepub:oai:gup.ub.gu.se/237002" >
Patterns of finaste...
Patterns of finasteride use in the male populations of four Nordic countries: A cross-national drug utilization study
-
Kjaerulff, T. M. (författare)
-
Ersboll, A. K. (författare)
-
Green, A. (författare)
-
visa fler...
-
Emneus, M. (författare)
-
Pukkala, E. (författare)
-
- Bolin, Kristian (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för nationalekonomi med statistik,Centrum för hälsoekonomi (CHEGU),Department of Economics,Centre for Health Economics
-
Stavem, K. (författare)
-
Iversen, P. (författare)
-
Brasso, K. (författare)
-
Hallas, J. (författare)
-
Thygesen, L. C. (författare)
-
visa färre...
-
(creator_code:org_t)
- 2016-02-22
- 2016
- Engelska.
-
Ingår i: Scandinavian Journal of Urology. - : Informa UK Limited. - 2168-1805 .- 2168-1813. ; 50:3, s. 220-227
- Relaterad länk:
-
https://gup.ub.gu.se...
-
visa fler...
-
https://doi.org/10.3...
-
visa färre...
Abstract
Ämnesord
Stäng
- Objective Finasteride 5 mg is a drug used to treat prostate hyperplasia. Little is known about its pattern of usage. This cross-national analysis of individual-level data from Denmark, Finland, Norway and Sweden was undertaken to appraise its usage and describe cross-national differences. Materials and methods Individual-level data from nationwide prescription registers in Denmark (1995-2009), Finland (1997-2010), Norway (2004-2009) and Sweden (July 2005-2011) were used to examine cross-national finasteride utilization patterns in the adult male population (>= 15 years). The study presents period prevalences, incidence rates, waiting time distributions and Lorenz curves. Results During the study period, 295,620 men had at least one prescription redemption of finasteride 5 mg, and there were approximately 3 million dispensing events of finasteride prescriptions in the four Nordic countries. Different patterns of finasteride use were observed among the four Nordic countries. The period prevalence was markedly higher in Finland and Sweden than in Denmark and Norway. In 2009, period prevalences were 18.2/1000 males in Finland and 12.0/1000 males in Sweden compared to 6.7/1000 males in Norway and 4.9/1000 males in Denmark. Incidence rates of finasteride use for Finland, Norway and Sweden were about three times that for Denmark in 2008-2009. Long-term use of finasteride was found in all four Nordic countries with a high ratio between prevalent and incident users. Conclusion Despite resemblances regarding political systems and healthcare services in the Nordic countries, differences in finasteride utilization were found across Denmark, Finland, Norway and Sweden. RAMS P, 1994, BRITISH MEDICAL JOURNAL, V308, P929
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine (hsv//eng)
Nyckelord
- Benign prostatic hyperplasia
- cross-national
- drug utilization
- finasteride
- Nordic countries
- pharmacoepidemiology
- serotonin reuptake inhibitors
- pharmacoepidemiologic research
- prostatic
- hyperplasia
- cohort
- pregnancy
- denmark
- risk
- Urology & Nephrology
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Kjaerulff, T. M.
-
Ersboll, A. K.
-
Green, A.
-
Emneus, M.
-
Pukkala, E.
-
Bolin, Kristian
-
visa fler...
-
Stavem, K.
-
Iversen, P.
-
Brasso, K.
-
Hallas, J.
-
Thygesen, L. C.
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
- Artiklar i publikationen
-
Scandinavian Jou ...
- Av lärosätet
-
Göteborgs universitet